Chemiluminescent Nanomicelles for Imaging Hydrogen Peroxide and Self-Therapy in Photodynamic Therapy by Chen, Rui et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2011, Article ID 679492, 9 pages
doi:10.1155/2011/679492
Research Article
Chemiluminescent Nanomicelles forImagingHydrogen
PeroxideandSelf-Therapy inPhotodynamic Therapy
Rui Chen,1 Luzhong Zhang,1 Jian Gao,2 Wei Wu,1 Yong Hu,2 and XiqunJiang1
1Laboratory of Mesoscopic Chemistry and Department of Polymer Science and Engineering,
College of Chemistry and Chemical Engineering, Nanjing University, Nanjing 210093, China
2National Laboratory of Solid State Microstructure and Department of Material Science and Engineering,
Nanjing University, Nanjing 210093, China
Correspondence should be addressed to Yong Hu, hvyong@nju.edu.cn and Xiqun Jiang, jiangx@nju.edu.cn
Received 20 January 2011; Revised 18 March 2011; Accepted 24 March 2011
Academic Editor: Zhen Cheng
Copyright © 2011 Rui Chen et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Hydrogen peroxide is a signal molecule of the tumor, and its overproduction makes a higher concentration in tumor tissue
compared to normal tissue. Based on the fact that peroxalates can make chemiluminescence with a high eﬃciency in the presence
of hydrogen peroxide, we developed nanomicelles composed of peroxalate ester oligomers and ﬂuorescent dyes, called peroxalate
nanomicelles (POMs), which could image hydrogen peroxide with high sensitivity and stability. The potential application of the
POMs in photodynamic therapy (PDT) for cancer was also investigated. It was found that the PDT-drug-loaded POMs were
sensitive to hydrogen peroxide, and the PDT drug could be stimulated by the chemiluminescence from the reaction between
POMs and hydrogen peroxide, which carried on a self-therapy of the tumor without the additional laser light resource.
1.Introduction
Reactive oxygen species (ROS), a vital substance in organ-
isms, not only involved in many signaling pathways that
maintain cellular homeostasis in physiological processes [1]
but also can induce severe damage in turn which is called
oxidative injury [2]. Hydrogen peroxide (H2O2), one of
the ROS, produced in cellular mitochondria, plays a major
role in mediating cell growth and apoptosis [3]. In healthy
organs, cells produce necessary H2O2 to mediate diverse
physiological progresses. However, abnormal overproduc-
tion implicates the development of various pathological
conditions,evenseverediseases, suchas cancer.Moreover, its
concentration spans four orders of magnitude from 10−8 M
inproliferationto10−4 Min apoptosis[4].Therefore, hydro-
gen peroxide is a very important signaling molecule acted as
an intracellular indicator in the development of cancer [5].
R e c e n t l y ,t h ed e t e c t i o no fh y d r o g e np e r o x i d ei nv i t r oo r
in vivo has been received much interests [6–8]. By using ﬂu-
orescence probe techniques, the concentration of hydrogen
peroxide can be obtained through ﬂuorescence intensity,
helpingustounderstandthestateofcellsunderphysiological
and pathological conditions [9]. Another way is peroxalate
chemiluminescence (POCL) whose mechanism can be sum-
marized in two progresses [10]. First, peroxalate derivatives
can be oxidized only by hydrogen peroxide to generate
a high-energy and unstable intermediate: dioxetanedione;
then, the intermediate degrades to carbon dioxide as well
as transfers energy to nearby molecules, such as ﬂuo-
rescent dye, to give a particular ﬂuorescence [11, 12]. Using
such a feature, a new type of imaging H2O2 is oﬀered as
reported like peroxalate polymeric nanoparticles [13]. These
nanoparticleshaveattractiveadvantagesbeyondﬂuorescence
probe, such as tunable wavelength emission, excellent sensi-
tivity, and high speciﬁcity for H2O2,s ot h e yc a nb ew i d e l y
applied in the diagnosis of the diseases related to H2O2 [14].
However,amajorbarriertoPOCL-basedsystemsapplication
is that peroxalate derivatives are not so stable and inclined
to hydrolyze in aqueous or protic solvents [15]. Therefore,
t h ep r o t e c t i o no fp e r o x a l a t ee s t e r sf r o mh y d r o l y s i si st h ek e y
factor to peroxalate NPs, for example, the formation of min-
isize organic reactor in aqueous systems through copolymer2 Journal of Biomedicine and Biotechnology
micelles [16]o rm i c r o e m u l s i o n s[ 17]. Meanwhile, with the
peroxalate esters and the ﬂuorescent dyes together in the
same phase, the energy transfer is expected to be improved
[18].
Photodynamic therapy (PDT) is a new technology for
cancer treatment. Photodynamic agents can be excited by
laser with speciﬁc wavelength, transfer energy to the nearby
oxygen, generate strong active singlet oxygen molecules.
Then singlet oxygen causes microvascular acute injury, and
blood vessel blockage in tumor and induces tumor cells
apoptosis, achieving the purpose of local treatment [19].
However, the conventional photodynamic therapy in cancer
treatment faces many problems [20]. These photodynamic
drugs are hydrophobic and can only dissolve in an organic
solvent, which is diﬃcultly to be directly injected into
the body. Conventional excitation laser light, ranging from
600nm to 700nm, cannot reach tumor site deeper than
10mm from the skin. In addition, in the photodynamic
treatment, the tumor localization must be accurately distin-
guished, because excitation light should only irradiate the
tumor tissue, without damaging the normal organs [21].
Therefore, the general photodynamic therapy can only treat
superﬁcial tumors, limiting its clinical applications.
In this paper, a novel PDT method is developed by
integrating peroxalate ester oligomers, ﬂuorescent dyes, and
photodynamic drugs simultaneously inside the PEG-PCL
micelles. The hydrophobic core of PEG-PCL micelles can
protecttheperoxalateesteroligomerfromdirectlycontacting
the water and postpone their hydrolysis. And the hydrophilic
PEG shell outside the PEG-PCL micelles stabilizes these
micelles in the aqueous solution, giving them long circula-
tion in the blood, which makes them suitable to be used
in biomedical ﬁeld. The energy between the peroxalate and
H2O2 reaction is eﬀectively transferred to the ﬂuorescent
dyes within a conﬁned space, and then dyes release the pho-
ton energy for PDT. Within the same micelle, photodynamic
drugs easily get the chemiluminescence to generate active
singlet oxygen molecules to kill cancer cells. Further, photo-
dynamic drugs encapsulated inside peroxalate nanomicelles
(POMs) not only improve their solubility in aqueous
solution, but also can be delivered to the tumor site and
increase the drug concentration inside the tumor due to
the small size of POMs [22]. All can improve the eﬀect of
photodynamic therapy with the PDT drug-loaded POMs.
Since the excitation is endogenous and does not require
external laser light source, this inner “light stick” can be
applied in PDT wherever inside the body, no matter how
the tumor is deep or close to the skin. The coencapsulated
ﬂuorescent dye as a light source for a photosensitizing PDT
drug is feasible [23], and intraparticle energy transfer and
ﬂuorescence photoconversion are theoretically and experi-
mentally valid [24]. Evidence exists that the apoptosis of
tumor cell mainly depends on the content of singlet oxygen,
rather than that of hydrogen peroxide [25]. The presence of
excess hydrogen peroxide is not only toxic to the normal
tissues and cells, but also can induce a malignant tumor.
It is very important to reduce the content of hydrogen
peroxide and increase the singlet oxygen concentration in
the tumor site. Therefore, these PDT drugs-loaded POMs are
valuable on the function that not only eﬀectively consumes
thehydrogenperoxideinthetumorsite,butalsotransfersthe
H2O2 to singlet oxygen through the PDT method. It should
be a partial solution to the shortcoming of PDT method
such as the short laser wavelength and diﬃculty in reaching
the internal tumor inside the body and have a potential
application in photodynamic therapy ﬁeld.
2.Materialsand Methods
2.1. Materials. Methoxypolyethyleneglycol (MPEG, Mw:
2kDa,Fluka)wasdried invacuumat85◦Cfor4hoursbefore
use. E-caprolactone (CL, Sigma) was dehydrated by CaH2
overnight at room temperature and distilled under reduced
pressure. Stannous octoate (Sigma) is used as received.
Oxalyl chloride (Acros) was distilled under reduced pressure
beforeuse.4-Hydroxybenzylalcohol(AlfaAesar),1,8-octan-
ediol (Alfa Aesar), 9, 10-diphenyl anthracene (ACROS),
rubrene (ACROS), rhodamine B (ACROS), mesotetraphen-
ylporphine (TPP, ≥97%, Sterm), and aqueoushydrogen per-
oxide (H2O2, 30%, Sinopharm Chemical Reagent Co.) were
used as received. All the other chemicals were of analytical
grade and were used without further puriﬁcation.
2.2. Synthesis of Poly(ethyleneglycol)-poly(caprolactone)
(PEG-PCL) and Peroxalate Ester Oligomer. PEG-PCL was
synthesized byaclassicalring-openingpolymerizationmeth-
od. Brieﬂy, a small amount of stannous octoate (0.1%
wt/wt) was added into a polymerization tube containing
MPEG (3g, 1.5mmol) and CL monomer (9.3mL). The tube
was sealed oﬀafterbeingevacuatedand thenimmersed in oil
bath at 130◦C for 48 hours. Then the crude polymerization
product was dissolved in CH2Cl2 and precipitated in an
excess mixture of n-hexane and ethyl (v/v:4/1) and then
ﬁltered and redissolved in CH2Cl2. After concentrated with
a rotary evaporator, the ﬁnal product was dried in vacuum.
Molecular weight of copolymer was determined by a gel
permeation chromatography (GPC, Waters 515 systems)
equipped with Waters 525 pump, Waters 2487 Ultraviolet
absorbance Detector, and Wyatt Technology Optilab rEX
refractive index detector and an STYRAGEL HR3, HR4, and
HR5 (300 × 7.8mm) columns in tetrahydrofuran (THF)
solution. The poly-dispersity index was calculated based on
polystyrene standards with molecular weights in the range
from 900 to 1.74 × 106 g/mol.
Peroxalateesteroligomerwas synthesized with 4-hydrox-
ybenzyl alcohol (16mmol), 1, 8-octanediol (2.4mmol) and
oxalyl chloride (18.3mmol). These two kinds of dialcohol
were ﬁrst dissolved in dry tetrahydrofuran (THF, 10mL),
with the addition of triethylamine (40mmol) by an injector
under vacuum. The mixture was kept at 0◦Ca n dt h e n
added to oxalyl chloride in dry tetrahydrofuran (20mL)
protected by a nitrogen atmosphere. The reaction was
kept at room temperature overnight and quenched with
a saturated brine solution. The product was extracted with
ethyl acetate and the combined organic layers were dried
by anhydrous Na2SO4 over 8 hours. After concentrated
under vacuum, it was isolated by precipitating in excessJournal of Biomedicine and Biotechnology 3
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Figure 1: (a) FT-IR and (b) 1H-NMR spectra of peroxalate ester
oligomers.
dichloromethane/hexane (v/v:1/1) solution, then ﬁltered,
and dried in vacuum. The chemical structure of the product
was measured with FT-IR (Bruker, Vector 22) using the solid
product directly and 1H-NMR (Bruker DQX-300) in CDCl3
solution.
2.3. Preparation of Chemiluminescent Nanomicelles. The na-
nomicelles were achieved by the self-assemble block copoly-
mers through a cosolvent evaporation method [16]. PEG-
PCL (50mg), peroxalate esters oligomer (5mg), and the
ﬂuorescent dye rubrene (1mg) were ﬁrst dissolved in 2mL
of acetone. The mixture was added dropwise into deionized
water (20mL) to form micelles with magnetic stirring. Then
the organic solvent was removed under reduced pressure at
0◦C, and the resulting micelle solution was used for further
experiments.
The hydrodynamic diameter and size distribution of
the as-prepared micelles were determined by dynamic light
scattering (DLS) using a Brookhaven BI-9000AT system
(Brookhaven Instruments Corporation, USA) at a concen-
tration of 1mg/mL in deionized water. Morphology of these
micelleswasconductedontransmission electronmicroscopy
(TEM, JEM-100S, JEOL, Japan).
2.4. Chemiluminescent Characterization of POMs. The na-
nomicelles solution was used directly with a ﬁnal concent-
ration of2.5mg/mL indeionized water. The imagesofchem-
iluminescence produced by POMs and diﬀerent concentra-
tion of hydrogen peroxide solution (in phosphate buﬀer pH
7.4, 0.1M) in a 96-well plate were caught by an imaging
system equipped with a −29◦C CCD (EC3, UVP). And
the mean density of chemiluminescence was statistical by
the software. The chemiluminescent intensity of POMs and
diﬀerent concentration of hydrogen peroxide solution (in
phosphatebuﬀerpH7.4,0.1M)weremeasuredusingalumi-
nometer (YN FG-1, Xunjie Corporation, China) and each
withthreetimesmeasurements. Chemiluminescentemission
spectrum of peroxalate ester oligomers (5mg) and dyes
(1mg) in dimethyl phthalate (2mL) with hydrogen peroxide
(200μL, 2μM) was measured using a ﬂuorometer spectroﬂu-
orometer (RF-5301-PC, Shimadzu) with a turn-oﬀ lamp.
The stability of POMs in aqueous system was investigated
by incubating them in deionized water for various time
and then mixed with 0.2μM hydrogen peroxide solution (in
phosphate buﬀer pH 7.4, 0.1M). The chemiluminescent
intensity was subsequently measured for 100 seconds using
a luminometer (YN FG-1, Xunjie Corporation, China), and
the integrated areas under CL intensity curves were calcu-
lated as the value.
2.5. Preparation of TPP-Encapsulated POMs. Mesotetra-
phenylporphine (TPP) was a kind of drug used in photo-
dynamic therapy (PDT). TPP-encapsulated POMs were pre-
pared using the same method as described above with TPP
(1mg) dissolved in acetone. The size of TPP-encapsulated
POMs was also investigated by DLS. The chemiluminescence
intensity ofnanomicelles with TPP or withoutTPP was mea-
sured using a luminometer, at thesame time, theinﬂuence of
TPP to the CL of POMs was also observed.
2.6. The Antitumor Properties of TPP-Encapsulated POMs.
Cytotoxicity of TPP-loaded nanomicelles against two kinds
of cancer cell lines was assessed by 3-(4, 5-dimethylthiazolyl-
2)-2, 5-diphenyltetrazolium bromide (MTT) assay. 100μL
cells with a density around 5,000cells/well were seeded in
96-well plate and were grown in completed media having
90% Dulbecco’s Modiﬁed Eagle Media (DMEM), 10% fetal
bovine serum, and 100units/mL penicillin/streptomycin.
The cells were maintained at 37◦Cu n d e r5 %C O 2 for 24
hours, then diﬀerent POMs groups and H2O2were added
into the cultured media and incubated for another 24
hours. Cytotoxicity with or without H2O2-treated cells
was compared in each drug group. The control cells and
only H2O2-treated cells were also cultured under the same
condition. MTT in phosphate buﬀer saline (PBS) was added
into each well and incubated for 4 hours after the media
was refreshed. Then the solution was discarded and dimethyl
sulphoxide (DMSO, 150μL) was added into the wells. The
optical intensity was measured at 570nm using microtiter
plate reader. Data were expressed as an average of three
times.4 Journal of Biomedicine and Biotechnology
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Figure 2: (a) Hydrodynamic diameter distribution and (b) TEM image of the nanomicelles.
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Figure 3: (a) Imaging of chemiluminescence produced by the POMs (2.5mg/mL) with H2O2 at various concentrations; (b), (c), and (d)
Correlation of the POMs (2.5mg/mL) to various concentrations ofH2O2 in PBS under diﬀerent operating voltage (OV). (b) OV = −500eV;
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Figure 4: Chemiluminescence emission spectra of peroxalate ester
oligomers and diﬀerent dyes in dimethyl phthalate in the presence
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Figure 5: Stability of the POMs in deionized water. POMs:
2.5mg/mL, H2O2:0 . 2μM, OV = −550eV.
3.Resultsand Discussion
3.1. The Composition of the Nanomicelles. The amphiphilic
copolymer PEG-PCL was chosen as the scaﬀold of the POMs
because it is biodegradable and biocompatible that had been
extensively used for drug delivery [26, 27]. The hydrophilic
PEG corona should enhance the biocompatibility and sta-
bility in physiologic environments, while the hydrophobic
PCLcorescouldstabilize encapsulatedperoxalate estersfrom
water hydrolysis. In the present work, the copolymer PEG-
PCL was synthesized by ring-opening polymerization, and
its molecular weight was determined by GPC to be 12kDa
with polydispersity index (PI) of 1.32. Peroxalate ester
oligomer was synthesized with 4-hydroxybenzyl alcohol, 1,
8-octanediol, and oxalyl chloride. The structure of product
was conﬁrmed by FT-IR and 1H-NMR (Figure 1). In
FT-IR spectrum, the two groups of split peaks around
1732cm−1/1688cm−1 and 1193cm−1/1165cm−1 indicated
the structure of mixed aromatic/aliphatic peroxalates. In 1H-
NMRspectrum, thecharacteristic resonances of7.3ppm(b),
5.4ppm (c), 4.3ppm (a), and 1.4ppm (d) were observed,
which further identiﬁedthis structure. The molecular weight
of peroxalate ester oligomer determined by GPC was 600Da
with PI of 1.21. Thus, it was clear that the oligomer
synthesized had a trimer structure of peroxalate ester based
on GPC result. During the preparation procedure of POMs,
peroxalate ester oligomers together with ﬂuorescent dyes
could be totally encapsulated inside the hydrophobic core of
PEG-PCL nanomicelles, which could protect the peroxalate
from contacting the water and postpone the hydrolysis. The
hydrophilicPEGsegment wouldsurround outsidethePOMs
to stabilize these micelles in the aqueous solution.
3.2. The Size and Morphology of POMs. Peroxalate ester oli-
gomer and the ﬂuorescent dye (rubrene) were encapsulated
in the PEG-PCL copolymer micelles forming the POMs
during preparation procedure. As determined by DLS, the
obtained POMs had a number-weighted hydrodynamic
diameter of 119 ± 0.9nm (Figure 2(a)). The transmission
electron microscopic(TEM) image manifested that these na-
nomicellesweresphericalinoutlinewithanaveragediameter
of about 60nm (Figure 2(b)), which is smaller than that
from DLS because they were observed in the dry state. The
small size of the nanomicelles should make them suitable for
imaging hydrogen peroxidein cellularmitochondria because
micelles in this size range had a higher opportunity for cell
penetrating [28].
3.3. Chemiluminescence of POMs with Hydrogen Peroxide.
These obtained POMs reacting with hydrogen peroxide
produced high-energy intermediate, which could chemically
excite ﬂuorescent dye to give an extent chemiluminescence.
Although its intensity was too weak to be recognized by
naked eye, the image of chemiluminescence could be
acquired by a low-temperature CCD camera. In Figure 3(a),
the chemiluminescence image of hydrogen peroxide and
POMs in a 96-well plate was shown. It was clear thatwith the
increase of the hydrogen peroxide concentration from 0.025
to 3μM( i nP B Sp H= 7.4), the brighter wells could be seen.
The quantitative analyses above the image conﬁrmed that
the higher hydrogen peroxide concentration was, the higher
chemiluminescence intensity would be.
Meanwhile,thechemiluminescenceintensitywas linearly
related to the concentrations of hydrogen peroxide. As
shown in Figure 3(b), the chemiluminescence intensity
increased linearly with the concentration of the hydrogen
peroxide in the range of 0.1–1μM, which indicated that the
concentration hydrogen peroxide in the cells or organs could
be quantitatively calculated according to the standard curve.
Further, by changing operating voltage of luminometer,
the sensitivity of the device was adjusted and adopted to
cover both lower (Figure 3(c))a n dh i g h e r( F i g u r e3(d))
concentration ranges. These results demonstrated that the
POMs were quite sensitive to hydrogen peroxide and could6 Journal of Biomedicine and Biotechnology
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All concentrations of POMs were 2.5mg/mL, OV = −550eV.
be used to detect physiological concentration of hydrogen
peroxide.
The chemical reaction between peroxalate and hydrogen
peroxide formed an intermediate 1, 2-dioxetanedione which
was potential to excite a variety of ﬂuorescent dyes, suitable
for a particular application. The tunable wavelength of
peroxalate chemiluminescence system was investigated by
encapsulating diﬀerent dyes in the POMs and measuring
theiremission spectra.Figure4demonstratedthatperoxalate
esters oligomers could excite diphenyl anthracene, rubrene,
and rhodamine in the presence of hydrogen peroxide, pro-
ducing ﬂuorescence at 430, 560, and 600nm, respectively.
The chemiluminescence emission wavelength could be read-
ily tuned to near infrared region by using a near-infrared
ﬂuorescentdyeandthereforethismethod canbeusedpoten-
tiallyindeeptissueimaging owingtotheminimaltissuescat-
tering and absorption to the near infrared [29].
Although the POMs have been proved a good carrier
to detect the H2O2 in the aqueous solution, the most chal-
lenging matter of this system is the instability of peroxalate
against water because of a fast hydrolysis in aqueous
solutions which makes them unsuitable for physiological
applications. However, the encapsulation of peroxalate esters
oligomers inside the PEG-PCL micelles could protect them
from water hydrolysis by providing a hydrophobic environ-
ment with low water permeability [30]. Hence, we investi-
gatedthestabilityofthesePOMsbyincubatingtheminwater
for diﬀerenttime and measuring their chemiluminescence in
the presence of hydrogen peroxide. Figure 5 demonstrated
the chemiluminescence intensity from the reaction between
peroxalate esters, and H2O2 decreased as the incubation
time in water extended. The POMs had a half-life longer
than 2 hours, suggesting that the POMs eﬀectively prevented
the peroxalate esters from water hydrolysis, compared to an
analogous work with a half-life of 30min [16]. It suggested
that the polymer nanomicelles eﬀectively improved the
stability of the peroxalate esters. The improved stability of
the peroxalate ester oligomers should allow them to image
hydrogen peroxide in physiological condition.
3.4. Characterization of the TPP-Encapsulated POMs. The
photodynamic therapy agent (mesotetraphenylporphine,
T P P )w a se n c a p s u l a t e di nP O M su s i n gt h es a m em e t h o da s
described above. And the size of TPP-encapsulated POMs is
to have similar average size with no TPP-encapsulated POMs
by DLS measurement. As shown in Figure 6(a),t h eT P P -
encapsulated POMs did not have detectable luminescence
because the high-energy intermediate could not directly
transfer chemical energy to TPP molecule. Although POMs
could not directly excite TPP, it could stimulate rubrene for
a remarkable chemiluminescence. Meanwhile, with the same
concentration of POMs and rubrene, the addition of TPP
weakens the ﬂuorescence of rubrene dye, which indicated
that part of energy had transferred to TPP. Rubrene played
as an eﬀective switchover for transferring chemical energy to
photon energy.
In order to further verify whether TPP has absorbed the
ﬂuorescence produced by rubrene, a subtle designed exper-
iment was carried on. According to the work reported [10],
in the absence of ﬂuorescence dyes, the high-energy inter-
mediate dioxetanedione can maintain its energy for a while
until being exposed to the dyes. In this experiment, ﬁrstly,
only POMs with and without TPP were incubated in the
presence of 0.2μMH 2O2. No luminescence was observed
in these systems as displayed in Figure 6(b).B o t ho ft h e s e
t w os y s t e m sh a dn or u b r e n ei n s i d et h e m .A f t e r1 0m i n u t e s ,
when 0.2mg rubrene was added into these two kinds of
POMs, respectively, signiﬁcant chemiluminescence signalsJournal of Biomedicine and Biotechnology 7
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Figure 7: The cytotoxicity of H2O2 to (a) C6 and (b) LoVo cell lines at various concentrations in PBS (pH = 7.4); (c) the cytotoxicity of a
diversity of POMs to C6 cell lines without H2O2. The cytotoxicity of a diversity of POMs to (d) C6 cells and (e) LoVo cells in the presence of
0.2μMH 2O2 or not, control means only H2O2 treated. All concentrations of POMs were 20μg/mL, Rubrene 0.3μg/mL, and TPP 2μg/mL.
Error bars indicate standard deviations from ≥3 measurements.8 Journal of Biomedicine and Biotechnology
were observed in the systems. However, the POMs encap-
sulating TPP showed a reduced chemiluminescence signal
compared to the blank POMs, which clearly supporting
that TPP absorbed part of the energy. Therefore, part of
the chemical energy from the reaction between POMs and
H2O2 could be transformed to light energy with the help of
rubrene, which indicated that the POMs and rubrene played
the role of a laser light in the presence of H2O2.E v e nt h e
chemiluminescence intensity was quite low compared with
a real laser source, this system opened a new window in the
PDT ﬁeld because no additional laser light was needed in
this system. For the traditional PDT system, external laser
light was needed to excite the PPT in the tumor treatment
procedure. However, restricted by its penetration depth of
thelaserlight,onlythetumorclosetotheskin couldbekilled
eﬀectively. In our system, The TPP drug was excited by the
inner chemiluminescence, which avoided the use of external
laser resource, consequently overcoming the problem of the
depthofthetumorsite.Furthermore,particleswith nanosize
had been proved to be accumulated in the tumor site by
the EPR eﬀect or targeting strategy [31]. So the TPP-loaded
POMs may greatly improve the therapy eﬀect compared to
the traditional PDT method.
3.5. The Anticancer Properties of the TPP-Encapsulated POMs.
The chemiluminescence radiation produced by the POMs
in the presence of hydrogen peroxide could act as an inner
light source to excite PDT drug to play curative eﬀect. To
verify the antitumor eﬀect of the TPP-encapsulated POMs,
in vitro cytotoxicity tests of the TPP-loaded POMs against
C6 and LoVo cell lines were conducted. As well known, high
concentration of hydrogen peroxide was cytotoxic to cells.
The control experiment of cells coincubated with diﬀerent
concentration of hydrogen peroxide was performed, and
their cytotoxicities were also evaluated by MTT assay. The
results clearly showed that the critical cytotoxic concentra-
tionof hydrogenperoxide is 0.3μM for C6 cells(Figure 7(a))
and 0.4μM for LoVo cells (Figure 7(b)), respectively, helping
us to choose a safe H2O2 concentration which was nontoxic
to cells but could acquire maximum chemiluminescence.
Therefore, hydrogen peroxide concentration 0.2μMw a s
chosen for all the cell cytotoxicity experiments. The cyto-
toxicity of diﬀerent kinds of POMs (e.g., with or without
rubrene) was checked without hydrogen peroxide treatment
(Figure 7(c)). No obvious cytotoxicity was observed at low
concentration except a slight cytotoxicity at high concen-
tration. So it seemed safe to conclude that the blank POMs
have no or little cytotoxicity against the test cells. Therefore,
the POMs used in the following experiment were ﬁxed on
the concentration of 20μg/mL, and the hydrogen peroxide
was the same concentration of 0.2μM. For C6 cells, when
they were treated with the POMs, in the absence of hydrogen
peroxide, no or little cytotoxicity was observed in all the
samples as shown in Figure 7(d).H o w e v e r ,w h e nh y d r o g e n
peroxide was added into the wells, an increasing cytotoxicity
is observed. Furthermore, C6 cells treated with the POMs
having both rubrene and TPP showed lowest cell viability
compared with other groups, indicating TPP and rubrene
having a combined antitumor eﬀect, which might resulted
from the chemiluminescence-stimulated PDT eﬀect of TPP.
Similar results were also observed in the LoVo cell line
cytotoxicity experiment (Figure 7(e)).
4.Conclusion
Chemiluminescent POMs were successfully developed to
image tumor signal molecules: hydrogen peroxide. These
POMs could improve the stability of peroxalates in aqueous
system and were sensitive to low concentration of hydrogen
peroxide within the physiological range. According to the
linear correlation between chemiluminescent intensity and
the concentration of hydrogen peroxide, a facile and robust
approach for monitoring hydrogen peroxide molecules was
established, which should be helpful to clinical diagnosis.
When PDT drug TPP was encapsulated inside the POMs
together with rubrene, the TPP-encapsulated POMs per-
formed an anticancer property in the presence of hydrogen
peroxide which was stimulated by self-produced chemilu-
minescence not an external laser. This system enabled us to
open a new window in the PDT ﬁeld without using external
laser light resource to treat the malignant tumor.
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